医学英语翻译临床测试稿.doc

注:请不要改动或删除原文。请务必将个人信息填写完整。测试前请先填写测试译员信息姓名：李敏手机：座机：无QQ号： 16673924 MSN：无邮箱：开始时间： 19:00 结束时间：20:30以下测试请做成每段对照的格式，测试时间2-3小时。请做完之后速发回。英译中：1. An epidemiologic assessment of acute abdominal pain found that 10 diagnostic groups could be classified in outpatients complaining of abdominal pain on their first visit to primary care physicians: whole abdominal; epigastric; right subcostal; left subcostal; right flank; left flank; periumbilical; right-lower; mid-lower; and left-lower (table 1)1. The overall sensitivity of history taking and physical examination was poor. Specificity was highest in patients with epigastric pain caused by gastroduodenal diseases; right subcostal pain caused by hepatobiliary diseases; and mid-lower pain caused by gynecologic diseases.1、一个急腹症的流行病学评估发现门诊首诊以腹痛为主诉的病人按照诊断分类可分为十类：整个腹部、上腹、右肋下、左肋下、右胁腹部、左胁腹部、脐周、右下腹、中下腹、左下腹（表格 1）1。病史采集和体格检查的总体敏感性较差。特异性在胃十二指肠疾病引起的上腹部疼痛患者；肝胆疾病引起的右肋下痛患者；妇产科疾病引起的中下腹痛患者中最高。2. Unlike biliary colic, which lasts a maximum of six to eight hours, the pain of pancreatitis lasts days. Its onset is rapid, but not as abrupt as that with a perforated viscus; in many cases, the pain of pancreatitis reaches maximum intensity within 10 to 20 minutes. One characteristic of the pain that is present in about one-half of patients and suggests a pancreatic origin is band-like radiation to the back. Painless disease is uncommon (5 to 10 percent) but may be complicated and fatal.2、不像胆绞痛，最长持续六至八小时，胰腺炎的疼痛要持续数天。它发作很迅速,但不像内脏穿孔那么突然；在许多病例中；胰腺炎的疼痛在10 20分钟达到最大强度。在近一半的患者出现放射至背部的带状痛特点，这提示疼痛源于胰腺。无痛的疾病是不常见的（5%-10%），却可能很复杂并且是致命的。 The ASCOT trial found a lower rate of cardiovascular disease and death with a calcium channel blocker (amlodipine) compared to a beta blocker (atenolol). However, patients in the amlodipine arm had a significantly lower mean blood pressure at the end of the study (3/2 mmHg) 10. 央格鲁-斯堪的纳维亚人心脏事件试验（ASCOT）发现钙通道阻滞剂(氨氯地平)比受体阻断剂(阿替洛尔)有更低的患心血管疾病和死亡的概率。然而，服用氨氯地平病人手臂的平均血压在研究的最后都显著降低 (3/2毫米汞柱)10。3. Ramipriland perindoprilproduced better outcomes than placebo in the HOPE and EUROPA trials of patients at increased cardiovascular risk, but the blood pressure was significantly lower in the treated patients: 3.3/1.4 mmHg (with a greater difference overnight) in HOPE and 5/2 mmHg in EUROPA 11,12. (See Blood pressure management in patients with atherosclerotic cardiovascular disease.) 3、在对心血管风险增高病人的HOPE和EUROPA研究中,雷米普利和培哚普利比安慰剂疗效更佳,但治疗后病人血压明显降低：HOPE 为3.3/1.4mmHg(夜间变化较大)，EROPA 为5/2mmHg11.12。（见于动脉粥样硬化性心血管疾病病人的血压控制）5.In the VALUE trial of over 15,000 patients who had either prior atherosclerotic cardiovascular disease or at least one risk factor for an adverse cardiovascular outcome, amlodipineproduced better outcomes than valsartanbut also greater blood pressure reduction 13. When 5000 pairs were matched exactly for systolic blood pressure and other risk factors, the two groups had nearly identical rates of card